SCHEMBL23447201

SCHEMBL23447201

CCc1c(Br)cccc1C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.52
GABRG2 P18507 2/20 0.52
GABRB3 P28472 2/20 0.52
GABRB2 P47870 3/20 0.41
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
HPGD P15428 3/20 0.41
TSHR P16473 3/20 0.41
FAAH O00519 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 1/20 0.41
GABRB1 P18505 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2C P28335 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
HTR2B P41595 1/20 0.41
GABRA2 P47869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18469082 0.84 GABRA1 (0.62) GABRA1GABRG2GABRB3GABRB2CYP1A2
SCHEMBL16952660 0.84 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRB2CYP1A2
SCHEMBL19289752 0.81 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRB2CYP1A2
SCHEMBL1293277 0.79 GABRA1 (0.48) GABRA1GABRB2CYP1A2TSHRTAAR1
SCHEMBL1293421 0.79 GABRA1 (0.38) GABRA1GABRG2GABRB3GABRB2CYP3A4
SCHEMBL16956016 0.77 GABRA1 (0.32) GABRA1GABRB2
SCHEMBL31737293 0.77 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRB2CYP1A2
SCHEMBL9734713 0.77 GABRA1 (0.54) GABRA1GABRG2GABRB3GABRB2CYP1A2
SCHEMBL3417547 0.77 GABRA1 (0.54) GABRA1GABRG2GABRB3GABRB2CYP1A2
SCHEMBL9579249 0.77 GABRA1 (0.54) GABRA1GABRG2GABRB3GABRB2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021108198-A1 INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-06-03 WO disclosed